Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[S,S]-Reboxetine Add-On Trial: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN) Concomitantly Treated With Pregabalin.

NCT00334685 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00334685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00334685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[S,S]-Reboxetine Add-On Trial: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN) Concomitantly Treated With Pregabalin.
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
August 22, 2006
Completion date
October 11, 2007
Enrollment
136 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

pain